Narcisa Mandras received her PhD in Biological Sciences from Turin University, Turin, Italy, in 1994, her Qualification to practice the profession of Biologist from Turin University in 1996, and a PhD in Microbiology and Virology, School of Medicine, Turin University in 2001. She has been an Associate Professor (Microbiology and Clinical Microbiology) at the Department of Public Health and Pediatrics, Turin University, since 2021. She teaches Microbiology and Clinical Microbiology at the Department of Drug Science and Technology and the Department of Public Health and Pediatrics, at the University of Turin. Her research experience includes bacteriological and mycological diagnostics; antimicrobial agent in vitro activity towards bacteria and fungi; studies on the complex interaction between aspecific immunity and antimicrobial agents in bacterial and fungal infections; evaluation of immunomodulatory activity on the primary functions of phagocytes, such as phagocytosis; microbicide activity against endcellular microorganisms (Gram-positive and Gram-negative bacteria, yeasts); studies on interaction among antimicrobial agents, pathogens, and phagocytes (macrophages, monocytes, PMN) in healthy and immunocompromised subjects; and the immunomodulatory effect of antimicrobial agents on cytokine release by phagocytes from immunocompetent subjects and immunocompromised patients.
Prof. Dr. Luca Brazzi is the Chief of the Anaesthesia and Intensive Care Unit at Città della Salute e della Scienza Hospital in Turin, Deputy Director of the Anaesthesia and Intensive Care Residency Program, and
Residency School Coordinator at the University of Turin, Italy. He is a Member of the Board of the European Society of Anaesthesiology and Intensive Care (ESAIC). His research interests include ARDS, extracorporeal respiratory support, and simulation techniques for training.
